Recent Decade Saw No Change in Diabetes Prevalence in U.S. Adults
By Elana Gotkine HealthDay Reporter
FRIDAY, March 7, 2025 -- Between 2013 and 2023, there was no change in the prevalence of diabetes among U.S. adults, but glycemic control worsened, according to a research letter published online Feb. 27 in the Journal of the American Medical Association.
Kosuke Inoue, M.D., Ph.D., from the Beth Israel Deaconess Medical Center in Boston, and colleagues examined trends in the prevalence and control of diabetes among U.S. adults aged 20 years or older between 2013 and 2023 using data from the National Health and Nutrition Examination Survey.
A total of 24,263 adults were included in the unweighted study population; 4,623 had diabetes. The researchers found no significant change in the prevalence of diabetes, from 12.8 percent in 2013-2014 to 14.1 percent in 2021-2023. Among adults with a diagnosis of diabetes, mean hemoglobin A1c (HbA1c) levels were stable between 2013-2014 and 2017-2020, but they increased significantly from 2017-2020 to 2021-2023 (7.31 to 7.60 percent). Glycemic control rates were also stable between 2013-2014 and 2017-2020 but decreased from 2017-2020 to 2021-2023 (54.3 to 43.5 percent). Increases in mean HbA1c levels were mainly seen among young adults aged 20 to 44 years (7.43 to 8.51 percent), and they also had a significant decline in rates of glycemic control (57.4 to 37.1 percent). Across other age or sex subgroups, there were no similar patterns observed.
"Given the recent stagnation in mortality improvement among young adults with diabetes and the increased risk of adverse cardiovascular outcomes associated with poor glycemic control, public health and policy efforts are needed to improve diabetes control, especially in younger populations," the authors write.
One author disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-03-08 06:00
Read more

- FDA Approves Tablet Form of Evrysdi for Spinal Muscular Atrophy
- Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human
- Difficult Menopause Could Be Warning Sign For Future Dementia
- 10 Tips to Fall Back Asleep After Waking Up at Night
- Makers of Wegovy & Zepbound Cut Prices for Those Without Insurance
- Higher Calcium Intake Linked to Reduced Colorectal Cancer Risk
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions